AMD Intel CPU war

The CPU (central processing unit) war between Advanced Micro Devices (AMD) and Intel (INTC) began at Computex 2019 where both companies unveiled their next-generation PC CPUs. AMD unveiled its 7-nm (nanometer) Ryzen 3000 series built on its Zen 2 architecture, which beat Intel’s current CPUs in terms of pricing and performance.

Computex 2019: AMD’s and Intel’s CPU Battlefield

Ryzen 3000 series

The Ryzen 3000 series was hyped because it puts AMD ahead of Intel in process node technology. The Ryzen 3000 series is built on a smaller 7-nm node and Zen 2 architecture, which improves performance and power efficiency and reduces production cost.

The transition from Zen 1 to Zen 2 helped AMD improve its single-threaded performance by 32% and multithreaded performance by over 100% thanks to 50% more cores, higher frequencies, and double floating point throughput per core.

AMD’s flagship Ryzen 9 3900X CPU

AMD’s Ryzen 3000 series includes two Ryzen 7 and two Ryzen 5 CPUs, but the show stopper is the new higher range CPU Ryzen 9 3900X, which is above the Ryzen 7 series. For the first time, AMD will introduce 12 cores and 24 threads in the mainstream PC market with its Ryzen 9 CPU.

The Ryzen 9 3900X consists of two Client Computing Devices of six cores each and delivers similar and even better performance than Intel’s 12-core high-end desktop CPU Core i9 9920X at half the price. The Core i9 9920X CPU is priced at $1,189 without a cooler whereas Ryzen 9 3900X is priced at $499 and comes with a cooler.

AMD’s Ryzen 9 versus Intel’s i9

AMD claims that Ryzen 9 3900X delivers 14% better single-threaded performance and 6% better multi-threaded performance than the 9920X while consuming 105 watts of power as against 9920X’s 165 watts.

AMD will release its Ryzen 3000 series CPUs, comprising of Ryzen 9, 7, and 5, on July 7 (which is 07/07), as they are built on TSMC’s 7nm node.

Check out all the data we have added to our quote pages. Now you can get a valuation snapshot, earnings and revenue estimates, and historical data as well as dividend info. Take a look!

Latest articles

This year, Pfizer (PFE) stock has fallen 0.34% and Bristol-Myers Squibb (BMY) stock has fallen 6.48%. Both companies are focused on strengthening their position in the high-growth oncology and immunology markets. Let's take a closer look at each.

Walt Disney’s (DIS) latest movie, Toy Story 4, has reportedly broken records in the opening weekend with $118 million in sales. However, the opening weekend collection was behind analysts’ expectations of at least $150 million in the first weekend.

24 Jun

Will Home Depot’s Upward Momentum to Continue?

WRITTEN BY Rajiv Nanjapla

As of June 21, Home Depot (HD) was trading at $209.39, which implies a rise of 9.7% since the announcement of its first-quarter earnings on May 21. Also, the company was trading at a premium of 32.4% from its 52-week low of $158.09 and a discount of 2.8% from its 52-week high of $215.43.

On June 21, Aurora Cannabis (ACB) made an announcement that indicated that it will move towards higher margin vape products. In addition, the company also believes concentrates and edibles will command higher margins. In anticipation of this development, the company announced the expansion of its facility to capitalize on growth related to these segments.

Shares of Mondelēz International (MDLZ) are scaling new heights thanks to its stellar gains so far this year. Mondelēz stock is up 38.0% on a YTD (year-to-date) basis, and it closed at $55.25—just a shade lower than its 52-week high of $55.71—on June 21.

24 Jun

How Long Will Facebook's Libra Fuel Bitcoin Rally?

WRITTEN BY Mayur Sontakke, CFA, FRM

Ever since the news about Facebook’s (FB) cryptocurrency project broke, Bitcoin has rallied on the hope that Facebook’s entry in the space will help make cryptocurrencies mainstream. Facebook’s cryptocurrency will be called Libra and will be governed by an association with 28 founding members across industries.